Nail psoriasis significantly impairs health-related quality of life among patients with chronic plaque psoriasis - 16/03/14
Martin Okun, Global Pharmaceutical Research and Development, AbbVie Inc, North Chicago, IL, United States; Andrew Kageleiry, Analysis Group, Inc, Boston, MA, United States; James Signorovitch, Analysis Group, Inc, Boston, MA, United States; Min Yang, Analysis Group, Inc, Boston, MA, United States; Murali Sundaram, Global Health Economics and Outcomes Research, AbbVie Inc, North Chicago, IL, United States
Le texte complet de cet article est disponible en PDF. Design, study conduct, and financial support for the study were provided by AbbVie; AbbVie participated in the interpretation of data, review, and approval of the abstract; all authors contributed to the development of the publication and maintained control over the final content. |
Vol 70 - N° 5S1
P. AB177 - mai 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?